Cancer BiologybioRxiv
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
F. Haderk, C. Fernandez-Mendez, L. Cech…·T. G. Bivona
This study identifies a FAK-YAP signaling axis that drives drug-tolerant persister cells and residual disease in lung cancer, showing that inhibiting this axis improves tumor response to targeted therapies.
DOI 10.1038/s41467-024-47423-0